APPLICATION
NDA213593
TYPE
NDA
ORIGINAL APPROVAL
2022-08-30
LATEST ACTION
2022-08-30
ROUTE
ORAL
DOSAGE FORM
FOR SUSPENSION
MARKETING STATUS
Prescription
Products
KONVOMEP · ReferencePrescription
OMEPRAZOLE 2MG/ML, SODIUM BICARBONATE 84MG/ML · FOR SUSPENSION · ORAL
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.